- 米国企業
- Edesa Biotech, Inc.
Edesa Biotech, Inc.EDSA
時価総額
$1443.2万
PER
| 2015年 9月30日 | 2016年 9月30日 | 2017年 9月30日 | 2018年 9月30日 | 2020年 9月30日 | 2021年 9月30日 | 2022年 9月30日 | |
| Research and development | 1 | 2 | 2 | 2 | 3 | 18 | 13 |
| General and administrative | 3 | 3 | 3 | 3 | 3 | 6 | 5 |
| Loss from Operations | - | -4,908,356 | -5,224,546 | -5,078,250 | -6,400,842 | -23,681,332 | -18,370,790 |
| Reimbursement grant income | - | - | - | - | - | 10 | 780,257 |
| Interest income | - | - | - | - | - | 11,165 | 63,523 |
| Foreign exchange loss | -653,333 | 76,800 | 162,028 | -35,059 | -366 | - | -21,114 |
| Other income expense | - | - | - | - | - | - | 822,666 |
| Loss before income taxes | -2,806,229 | -5,018,880 | -5,029,848 | -5,038,149 | - | - | -17,548,124 |
| Income tax expense | 36,800 | 7,200 | 800 | 800 | 800 | 800 | 800 |
| Net Loss | -2,843,029 | -5,026,080 | -5,030,648 | -5,038,949 | -6,364,230 | -13,342,350 | 18 |
| Exchange differences on translation | - | - | - | - | - | - | -8,340 |
| Net Comprehensive Loss | - | - | - | - | -6,309,360 | -13,261,208 | -17,557,264 |
| Loss per common share - basic and diluted | - | - | - | - | - | - | -1.05 |